A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice
出版年份 2018 全文链接
标题
A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice
作者
关键词
Immune serum, Antibodies, Macaque, Enzyme-linked immunoassays, Antigens, Dengue virus, Vaccines, Viremia
出版物
PLoS Neglected Tropical Diseases
Volume 12, Issue 1, Pages e0006191
出版商
Public Library of Science (PLoS)
发表日期
2018-01-09
DOI
10.1371/journal.pntd.0006191
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus
- (2017) Petraleigh Pantoja et al. Nature Communications
- DNA-immunisation with dengue virus E protein domains I/II, but not domain III, enhances Zika, West Nile and Yellow Fever virus infection
- (2017) Jose L. Slon Campos et al. PLoS One
- Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus
- (2016) Wanwisa Dejnirattisai et al. NATURE IMMUNOLOGY
- Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort
- (2016) Leah C. Katzelnick et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment
- (2016) Neil M. Ferguson et al. SCIENCE
- Protective and immunological behavior of chimeric yellow fever dengue vaccine
- (2016) Scott B. Halstead et al. VACCINE
- Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant Epitope
- (2015) Luke N. Robinson et al. CELL
- Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice
- (2015) Satoru Watanabe et al. JOURNAL OF VIROLOGY
- Dengue vaccine: hypotheses to understand CYD-TDV-induced protection
- (2015) Bruno Guy et al. NATURE REVIEWS MICROBIOLOGY
- Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease
- (2015) Sri Rezeki Hadinegoro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America
- (2015) Luis Villar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers
- (2015) G. Fibriansah et al. SCIENCE
- Pichia pastoris-expressed dengue 3 envelope-based virus-like particles elicit predominantly domain III-focused high titer neutralizing antibodies
- (2015) Lav Tripathi et al. Frontiers in Microbiology
- A Dengue Virus Type 4 Model of Disseminated Lethal Infection in AG129 Mice
- (2015) Gregg N. Milligan et al. PLoS One
- Type I Interferon Signals in Macrophages and Dendritic Cells Control Dengue Virus Infection: Implications for a New Mouse Model To Test Dengue Vaccines
- (2014) R. Zust et al. JOURNAL OF VIROLOGY
- Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
- (2014) Maria Rosario Capeding et al. LANCET
- A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus
- (2014) Wanwisa Dejnirattisai et al. NATURE IMMUNOLOGY
- Dengue Viruses Are Enhanced by Distinct Populations of Serotype Cross-Reactive Antibodies in Human Immune Sera
- (2014) Ruklanthi de Alwis et al. PLoS Pathogens
- Functional Analysis of Antibodies against Dengue Virus Type 4 Reveals Strain-Dependent Epitope Exposure That Impacts Neutralization and Protection
- (2013) S. Sukupolvi-Petty et al. JOURNAL OF VIROLOGY
- The global distribution and burden of dengue
- (2013) Samir Bhatt et al. NATURE
- Pichia pastoris-Expressed Dengue 2 Envelope Forms Virus-Like Particles without Pre-Membrane Protein and Induces High Titer Neutralizing Antibodies
- (2013) Shailendra Mani et al. PLoS One
- The Potent and Broadly Neutralizing Human Dengue Virus-Specific Monoclonal Antibody 1C19 Reveals a Unique Cross-Reactive Epitope on the bc Loop of Domain II of the Envelope Protein
- (2013) S. A. Smith et al. mBio
- Dengue-specific subviral nanoparticles: design, creation and characterization
- (2013) Niyati Khetarpal et al. JOURNAL OF NANOBIOTECHNOLOGY
- Mosquirix (RTS,S): A Novel Vaccine for the Prevention of Plasmodium falciparum Malaria
- (2012) K. J. Wilby et al. ANNALS OF PHARMACOTHERAPY
- Antibodies against the Envelope Glycoprotein Promote Infectivity of Immature Dengue Virus Serotype 2
- (2012) Júlia M. da Silva Voorham et al. PLoS One
- Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions
- (2012) R. de Alwis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Fusion-Loop Antibody Enhances the Infectious Properties of Immature Flavivirus Particles
- (2011) I. A. Rodenhuis-Zybert et al. JOURNAL OF VIROLOGY
- Persistence of Circulating Memory B Cell Clones with Potential for Dengue Virus Disease Enhancement for Decades following Infection
- (2011) S. A. Smith et al. JOURNAL OF VIROLOGY
- In-Depth Analysis of the Antibody Response of Individuals Exposed to Primary Dengue Virus Infection
- (2011) Ruklanthi de Alwis et al. PLoS Neglected Tropical Diseases
- Enhanced Infection of Liver Sinusoidal Endothelial Cells in a Mouse Model of Antibody-Induced Severe Dengue Disease
- (2010) Raphaël M. Zellweger et al. Cell Host & Microbe
- The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity
- (2010) Martina Beltramello et al. Cell Host & Microbe
- Dengue vaccines: state of the art
- (2010) Sathyamangalam Swaminathan et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Optimization of conditions for secretion of dengue virus type 2 envelope domain III using Pichia pastoris
- (2010) Gaurav Batra et al. JOURNAL OF BIOSCIENCE AND BIOENGINEERING
- Genotype-Specific Neutralization and Protection by Antibodies against Dengue Virus Type 3
- (2010) James D. Brien et al. JOURNAL OF VIROLOGY
- Structure and Function Analysis of Therapeutic Monoclonal Antibodies against Dengue Virus Type 2
- (2010) S. Sukupolvi-Petty et al. JOURNAL OF VIROLOGY
- Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
- (2010) W. Dejnirattisai et al. SCIENCE
- The RTS,S malaria vaccine
- (2010) Sofia Casares et al. VACCINE
- Natural Strain Variation and Antibody Neutralization of Dengue Serotype 3 Viruses
- (2010) Wahala M. P. B. Wahala et al. PLoS Pathogens
- The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1
- (2010) Bimmi Shrestha et al. PLoS Pathogens
- Simple high-cell density fed-batch technique for high-level recombinant protein production with Pichia pastoris: Application to intracellular production of Hepatitis B surface antigen
- (2009) Chandrasekhar Gurramkonda et al. Microbial Cell Factories
- Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody
- (2009) W.M.P.B. Wahala et al. VIROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More